Since there was simultaneous upregulation of anti-angiogenic VHL and pro-angiogenic VEGF, CAM assay was employed as a means to directly asses the angiogenic potential of macrophages incubated with culture supernatant of normoxic or hypoxic breast cancer cells. The gene discussed is VHL; the disease is breast carcinoma.